Morphotek and AREVA Med to Collaborate on Lead-212 Targeted Alpha Therapies

EXTON, Pa. and COURBEVOIE, France, Mar. 31 (Korea Bizwire) — Morphotek®, Inc., a subsidiary of Eisai Inc., and AREVA Med, the AREVA Group medical subsidiary developing innovative therapies to fight cancer, announced today that they have entered into a collaborative project to assess the potential of a novel alpha radio-immunotherapy treatment in the fight against [...]